Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemokine Receptors-Structure-Based Virtual Screening Assisted by Machine Learning. | Pharmaceutics | 2023 | 36839838 | PubTator, text mining | PubMed |
| ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36834567 | PubTator, text mining | PubMed |
| CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential. | Biomolecules | 2023 | 36830702 | PubTator, text mining | PubMed |
| Bacterial degradation kinetics of poly(Ɛ-caprolactone) (PCL) film by Aquabacterium sp. CY2-9 isolated from plastic-contaminated landfill. | J Environ Manage | 2023 | 36822047 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer. | Aging (Albany NY) | 2023 | 36801818 | PubTator, text mining | PubMed |
| Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 36800576 | PubTator, text mining | PubMed |
| Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2023 | 36793272 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of PTTG Family and Prognosis and Immune Cell Infiltration in Gastric Cancer. | Stem Cells Int | 2023 | 36785594 | PubTator, text mining | PubMed |
| T lymphocyte cell: A pivotal player in lung cancer. | Front Immunol | 2023 | 36776832 | PubTator, text mining | PubMed |
| The reciprocal interactions between microglia and T cells in Parkinson's disease: a double-edged sword. | J Neuroinflammation | 2023 | 36774485 | PubTator, text mining | PubMed |
| Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19. | Nat Commun | 2023 | 36774347 | PubTator, text mining | PubMed |
| MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma. | Int J Mol Sci | 2023 | 36769082 | PubTator, text mining | PubMed |
| Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review. | Int J Mol Sci | 2023 | 36768537 | PubTator, text mining | PubMed |
| The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches. | Int J Mol Sci | 2023 | 36768342 | PubTator, text mining | PubMed |
| Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression. | Cancers (Basel) | 2023 | 36765704 | PubTator, text mining | PubMed |
| EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer. | Cancers (Basel) | 2023 | 36765579 | PubTator, text mining | PubMed |
| Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. | Front Immunol | 2023 | 36761737 | PubTator, text mining | PubMed |
| Hypermethylated WASF2: tumor suppressive role in head and neck squamous cell carcinoma. | Transl Cancer Res | 2023 | 36760387 | PubTator, text mining | PubMed |
| Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. | Transl Cancer Res | 2023 | 36760385 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=19